NCT03133871View on ClinicalTrials.gov

Evaluation of Scanoskin for the Assessment of Vitiligo

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

November 20, 2018

Study Completion Date

November 20, 2018

Conditions
Vitiligo
Trial Locations (1)

SW10 9NH

Chelsea and Westminster Hospital, London

All Listed Sponsors
lead

Chelsea and Westminster NHS Foundation Trust

OTHER

NCT03133871 - Evaluation of Scanoskin for the Assessment of Vitiligo | Biotech Hunter | Biotech Hunter